Australia
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.51 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
2 |
USD -3.92 M
|
June 30, 2024 | USD 2.04 | -5.56% |
|
Australia |
|
3 |
USD -8.41 M
|
June 30, 2024 | USD 4.80 | 5.03% |
|
Australia |
|
4 |
USD -16.12 M
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
|
5 |
USD -23.84 M
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
The Vaccines company in Australia with the highest Free Cash Flow is CSL Limited (ASX: CSL.AX) at USD 1.51 B.
The Vaccines company in Australia with the lowest Free Cash Flow is Immutep Limited (NasdaqGM: IMMP) at USD -23.84 M.
The top 10 Vaccines companies in Australia by Free Cash Flow are CSL Limited, Immuron Limited, Alterity Therapeutics Limited, Incannex Healthcare Limited and Immutep Limited.
The bottom 10 Vaccines companies in Australia by Free Cash Flow are Immutep Limited, Incannex Healthcare Limited, Alterity Therapeutics Limited, Immuron Limited and CSL Limited.